|
The Effects of Functional Electrical Stimulation (FES) and Exercise on the Quadriceps in Patients With Knee Osteoarthritis
RECRUITINGSponsored by Ankara City Hospital Bilkent
Actively Recruiting
SponsorAnkara City Hospital Bilkent
Started2025-01-03
Est. completion2025-12-30
Eligibility
Age50 Years – 65 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07309003
Summary
In our study, we aimed to compare the effects of functional electrical stimulation (FES) and an exercise program on quadriceps muscle strength and structural characteristics, as well as their impact on gait analysis, pain severity, and quality of life, in order to determine more effective and beneficial treatment programs for patients with knee OA.
Eligibility
Age: 50 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria: * Being between 50-65 years of age * Having knee OA (primary) according to ACR criteria * Having grade 2-3 knee OA according to the Kellgren-Lawrence classification * Having the ability to adhere to exercise regimens * Agreeing to participate in the study Exclusion Criteria: * Having a diagnosis of secondary OA * History of major knee trauma, surgery, or intra-articular steroid/hyaluronic acid injection in the last 6 months * Presence of active synovitis * Presence of neurological (Parkinson's, Alzheimer's, Polyneuropathy), endocrinological (diabetes mellitus), or vestibular disorders that could affect functional status, pain severity, or proprioception; or any disease that impairs these factors * Pulmonary or cardiovascular disease that contraindicates exercise * History of fracture and/or surgery in the lower extremity
Conditions2
ArthritisOsteoarthritis (OA) of the Knee
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorAnkara City Hospital Bilkent
Started2025-01-03
Est. completion2025-12-30
Eligibility
Age50 Years – 65 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07309003